Global Intestinal Pseudo-Obstruction Treatment Market Trends and Future Outlook to 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What CAGR And Valuation Are Anticipated For The Intestinal Pseudo-Obstruction Treatment Market?
The market size for treating intestinal pseudo-obstruction has experienced robust growth in the past few years. It is projected to rise from $23.46 billion in 2024 to $24.74 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.5%. Factors that contributed to this growth during the historical period include broader recognition and diagnosis, improvements in medical imaging technology, advancements in tests for gastrointestinal motility, and increased accessibility to global healthcare services.
The market for the treatment of intestinal pseudo-obstruction is set to experience a robust growth in the coming years. A projection of reaching $30.8 billion by 2029 with a compound annual growth rate (CAGR) of 5.6% is anticipated. Factors such as scientific research, development of new drugs, the advent of telemedicine, remote patient monitoring, patient knowledge dissemination, and flexible reimbursement policies are significant contributors to the growth during the forecast period. Upcoming trends that will shape this market include advancements in gastrointestinal motility testing, therapies involving immune system modulation, nutritional interventions, and the application of data analytics and artificial intelligence.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12995&type=smp
What Are The Primary Factors Supporting The Intestinal Pseudo-Obstruction Treatment Market Expansion?
The treatment market for intestinal pseudo-obstruction is anticipated to grow due to an increase in Parkinson’s disease cases. Parkinson’s disease, a neurodegenerative disorder, primarily targets the dopamine-producing neurons located in the substantia nigra region of the brain. Parkinson’s disease often contributes to the increased occurrence of Intestinal Pseudo-Obstruction (IPO) in patients as it impacts the enteric nervous system. This can lead to gastrointestinal dysmotility, potentially resulting in complications such as megacolon and intestinal blockage, which include acute colonic pseudo-obstruction. In December 2022, the Parkinson’s Foundation, a non-profit organization based in the US, reported a dramatic 50% increase in Parkinson’s disease (PD) diagnoses, with approximately 90,000 Americans diagnosed annually, up from the earlier estimate of 60,000. Furthermore, it is forecasted that the global count of Parkinson’s disease patients will reach 1.2 million by 2030. These escalating figures of Parkinson’s disease reinforce the expansion of the intestinal pseudo-obstruction treatment market.
Which Segments Define The Structure Of The Intestinal Pseudo-Obstruction Treatment Market?
The intestinal pseudo-obstruction treatmentmarket covered in this report is segmented –
1) By Drug Class: Antibiotics; Antidepressants; Antidiarrheals
2) By Treatment: Medication; Surgery; Diet; Decompression; Other Treatments
3) By Route Of Administration: Oral; Intravenous; Other Route Of Administrations
4) By Diagnosis: Physical Examination; Biopsy; Blood Test; Gastric Emptying Tests; Imaging Tests; Other Diagnosis
5) By End User: Clinic; Hospitals; Other End Users
Subsegments:
1) By Antibiotics: Broad-Spectrum Antibiotics; Narrow-Spectrum Antibiotics
2) By Antidepressants: Tricyclic Antidepressants (TCAs); Selective Serotonin Reuptake Inhibitors (SSRIs)
3) By Antidiarrheals: Loperamide; Bismuth Subsalicylate
Who Are The Primary Market Leaders In The Intestinal Pseudo-Obstruction Treatment Market?
Major companies operating in the intestinal pseudo-obstruction treatment market are F. Hoffmann-La Roche AG, Merck Sharp & Dohme Corp, Bayer AG, Sanofi S.A., AstraZeneca PLC, GSK PLC, Takeda Pharmaceutical Company Limited, Amgen PLC, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Mylan N.V., Biogen Inc., Penn Medicine, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Cipla Inc., Dr. Reddy’s Laboratories Ltd., Allergan PLC, Torrent Pharmaceuticals Limited, Basilea Pharmaceutica Ltd., Paratek Pharmaceuticals Inc., Melinta Therapeutics LLC, Tetraphase Pharmaceuticals Inc., Callisto Pharmaceuticals Inc.
Access The Complete Report Here:
What Regional Factors Are Accelerating Growth In The Intestinal Pseudo-Obstruction Treatment Market?
North America was the largest region in the intestinal pseudo-obstruction treatment market in 2024. The regions covered in intestinal pseudo-obstruction (IPO) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12995&type=smp
Browse Through More Reports Similar to the Global Intestinal Pseudo-Obstruction Treatment Market 2025, By The Business Research Company
Intestinal Pseudo Obstruction Treatment Global Market Report 2025
Gastrointestinal Bleeding Treatment Devices Global Market Report 2025
Animal Intestinal Health Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/animal-intestinal-health-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
